Glenmark - Welcome to Glenmark Pharmaceuticals
WEBAt Glenmark, we believe in enriching lives and making a difference to patients all over the world. We constantly strive to find new ways that pave the way for a healthier tomorrow. We are creating centers of excellence in dermatology, oncology and respiratory therapy.
About Us - Emerge - Glenmark Pharma
WEBGlenmark Pharmaceuticals Limited is a research‐led, global pharmaceutical company, having a presence across branded, generics, and OTC segments; with a focus in the therapy areas of Respiratory, Dermatology and Oncology.
Contact Us - Glenmark Pharmaceuticals
WEBTel No.: +91 22 4018 9999. Fax No.: +91 22 4018 9986. Contact Us : Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.
Latin America - Glenmark Pharmaceuticals
WEBGlenmark Latin America. We began our operations in the Latin American market by exporting branded formulations to the Caribbean countries. We currently have presence in 12 countries, with a focus on key markets like Brazil, Mexico and Argentina.
Products Overview - Glenmark Pharmaceuticals
WEBGlenmark has focused on developing branded and generic formulations for over 4 decades positively impacting lives globally. In branded formulations, we are focused on developing innovative products for markets such as India, Russia & CIS, Brazil, Asia and Africa.
Reports & Presentations - Glenmark Pharmaceuticals
WEBGlenmark’s Q1 FY 2024-25 Results. Glenmark’s Press Release and MDA Q1 FY 2024-25. Glenmark’s Investor Presentation Q1 FY 2024-25. Click for more. KNOW MORE.
Innovation - Glenmark Pharmaceuticals
WEBGlenmark’s pursuit of innovative drug discovery started over two decades ago with a vision to find cures for the unmet medical needs of patients across the globe by providing novel therapeutic options.
Newsroom - Glenmark Pharmaceuticals
WEBAug 19, 2024 · Glenmark Pharma reports consolidated revenue growth of 6.9%, EBITDA margin of 18.1%, and PAT margin of 10.5% YoY for Q1 FY 2024-25. Glenmark Pharmaceuticals receives ANDA approval for Topiramate Capsules USP, 15 mg and 25 mg.
Evolution - Glenmark Pharmaceuticals
WEBCollaboration propels innovation. Glenmark and Ichnos take a collaborative leap to accelerate innovation in finding cure for cancer with their alliance - ‘Ichnos Glenmark Innovation’.
R&D Pipeline - Glenmark Pharmaceuticals
WEBGlenmark’s R&D is committed to identifying products that fulfill unique and unmet medical needs in inflammation disorders, especially in respiratory and dermatology therapies and also oncology.